Cargando…
Diet-Induced Obesity Impairs Outcomes and Induces Multi-Factorial Deficiencies in Effector T Cell Responses Following Anti-CTLA-4 Combinatorial Immunotherapy in Renal Tumor-Bearing Mice
SIMPLE SUMMARY: Immunotherapy use has become standard for many patients with advanced kidney cancer; unfortunately, <50% of patients experience durable responses. Mounting evidence suggests that modifiable factors, such as diet and obesity, impact immunotherapy outcomes. Obesity, a major U.S. hea...
Autores principales: | Turbitt, William J., Boi, Shannon K., Gibson, Justin T., Orlandella, Rachael M., Norian, Lyse A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151089/ https://www.ncbi.nlm.nih.gov/pubmed/34064933 http://dx.doi.org/10.3390/cancers13102295 |
Ejemplares similares
-
The Antidiabetic Agent Acarbose Improves Anti-PD-1 and Rapamycin Efficacy in Preclinical Renal Cancer
por: Orlandella, Rachael M., et al.
Publicado: (2020) -
Obesity-Associated Myeloid-Derived Suppressor Cells Promote Apoptosis of Tumor-Infiltrating CD8 T Cells and Immunotherapy Resistance in Breast Cancer
por: Gibson, Justin T., et al.
Publicado: (2020) -
Targeting Glucose Metabolism to Enhance Immunotherapy: Emerging Evidence on Intermittent Fasting and Calorie Restriction Mimetics
por: Turbitt, William J., et al.
Publicado: (2019) -
Rapid Maturation of Effector T Cells in Tumors, but Not Lymphoid Organs, during Tumor Regression
por: Norian, Lyse A., et al.
Publicado: (2007) -
Obesity diminishes response to PD-1-based immunotherapies in renal cancer
por: Boi, Shannon K, et al.
Publicado: (2020)